Key result
Highly variable hyperglycemia in the ICU linked to ~6-fold higher in-hospital mortality vs normoglycemia.
Why the study?
Are glucose trajectory phenotypes associated with in-hospital mortality in ICU patients with non-traumatic stroke?
Cohort (n=11,177)
Yes
Are glucose trajectory phenotypes associated with in-hospital mortality in ICU patients with non-traumatic stroke?
Hazard Ratio: 5.766 (95% CI 4.319–7.699)
Highly variable hyperglycemia during the first 168 hours of ICU admission is strongly associated with increased in-hospital mortality in patients with non-traumatic stroke.
Non-traumatic stroke (NTS) is associated with high mortality, and dynamic glucose patterns may provide prognostic information beyond static glucose measurements. This study aimed to identify glucose trajectory phenotypes in ICU patients with NTS and evaluate their association with in-hospital mortality. This multicenter retrospective cohort study included ICU patients with NTS from MIMIC-IV, eICU, and NSICU. Glucose trajectories during the first 168 h after ICU admission were identified using latent class growth modeling. Associations with in-hospital mortality were assessed using Cox regression, Kaplan-Meier analysis, competing-risk analysis, and subgroup analyses. Incremental predictive value was evaluated using AUC, integrated discrimination improvement (IDI), net reclassification improvement (NRI), and median improvement in predicted risk. Among 11,177 patients, four glucose trajectory phenotypes were identified: normoglycemia (NG, n = 5,515), stable mild hyperglycemia (SMH, n = 3,425), persistent hyperglycemia (PH, n = 2,080), and highly variable hyperglycemia (HVH, n = 157). Compared with NG, SMH, PH, and HVH were progressively associated with higher in-hospital mortality in the fully adjusted model, with HRs of 1.668 (95% CI: 1.469-1.894), 2.406 (95% CI: 2.083-2.779), and 5.766 (95% CI: 4.319-7.699), respectively. HVH remained associated with increased mortality in both diabetic and non-diabetic patients. Adding glucose trajectories to baseline prediction models modestly improved AUC, IDI, NRI, and predicted risk classification across LASSO, Boruta, and BSS-BIC models. In ICU patients with NTS, glucose trajectory phenotypes were associated with different risks of in-hospital mortality, with HVH showing the strongest association. Glucose trajectories may provide additional prognostic information for risk stratification beyond static glucose measurements.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) conducted a cohort in Non-traumatic stroke (NTS) (n=11,177). Highly variable hyperglycemia (glucose trajectory phenotype) vs. Normoglycemia was evaluated on In-hospital mortality (HR 5.766, 95% CI 4.319-7.699). Highly variable hyperglycemia during the first 168 hours of ICU admission was associated with higher in-hospital mortality compared to normoglycemia (HR 5.766; 95% CI 4.319-7.699).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: